20 May 2003
Histological lesions and liver biochemistry depending on HCV genotype and viral load in patients (pts)with chronic hepatitis C:preliminary results
V. Liakina, D. Speiciene, A. Irnius, T. SemuchinieneMed Sci Monit 2003; 9(2): 11-0 :: ID: 15256
Abstract
Background:To assess the association of hepatitis C virus (HCV) genotypes and viral load with some biochemical parameters and liver histological lesions.Material/Methods:Thirty four pts with chronic hepatitis C (CHC)(15/44.1%male,19/55.9%female,mean age 48.2 years) were investigated.CHC diagnosis was confirmed by the presence of anti-HCV (EIA 2-nd generation,ABBOTT)and HCV RNA (AMPLICOR HCV,ROCHE). HCV viral load and HCV genotypes were detected by PCR amplification (AMPLICOR HCV MONITOR Test version 2.0,ROCHE; INNO-LIPA, INNOGENETICS). Biochemical liver tests were performed in all pts,while liver biopsy –in all,but one with hemophilia,and scored according Ishak and METAVIR.According to HCV genotype all pts were divided into two groups:gr.1 –28/82.4% pts had HCV genotype 1, gr.2 –6/17.6%–HCV genotype 2 and 3 (1/2.9%and 5/14.7%,respectively).The biochemical parameters (activity of ALT,AST, ALP,aGT and bilirubin)and extent of histological lesions (HAI,fibrosis,lymphoid aggregates and follicles,steatosis,bile duct damage)were compared in pts within and between groups depending on viral load –800000IU/ml. Results:Within gr.1 slightly higher,but not statistically significant scores of HAI and grade of fibrosis (6.0 ±1.8 vs 7.4 ±1.6;3.0 ±1.3 vs 4.0 ±1.0)were found in pts with higher viral load,while higher prevalence of steatosis in those pts was statistically significant (15.8%vs 66.7%,p800000 IU/ml)viral load.Higher scores of HAI and fibrosis as well as prevalence of lymphoid aggregates and follicles in pts with genotype 1 and higher viral load did not reach statistical significance.There were no differences of mean values of biochemical parameters depending on viral load neither within nor between 2 pts groups.
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952